These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3778276)

  • 1. DNA content abnormalities and prognosis in uveal melanoma.
    Meecham WJ; Char DH
    Arch Ophthalmol; 1986 Nov; 104(11):1626-9. PubMed ID: 3778276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of DNA ploidy as assessed with flow cytometry in uveal melanoma.
    Elavathil LJ; LeRiche J; Rootman J; Gallagher RP; Phillips D
    Can J Ophthalmol; 1995 Dec; 30(7):360-5. PubMed ID: 8963937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation.
    Mooy C; Vissers K; Luyten G; Mulder A; Stijnen T; de Jong P; Bosman F
    Br J Ophthalmol; 1995 Feb; 79(2):174-7. PubMed ID: 7696240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry measurement of nuclear RNA content in uveal melanoma.
    Chen TC; Char DH; Waldman F; Juster RP
    Ophthalmic Res; 1990; 22(3):187-93. PubMed ID: 2166933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA index and S phase fraction in uveal malignant melanomas.
    Hodge WG; Duclos AJ; Rocha G; Antecka E; Baines MG; Corriveau C; Brownstein S; Deschenes J
    Br J Ophthalmol; 1995 Jun; 79(6):521-6. PubMed ID: 7626566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
    Richardson RP; Lawry L; Rees RC; Rennie IG
    Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death.
    Damato B; Dopierala J; Klaasen A; van Dijk M; Sibbring J; Coupland SE
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3048-55. PubMed ID: 19182252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
    Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
    Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of DNA content in uveal melanomas by flow cytometry.
    Rennie IG; Rees RC; Parsons MA; Lawry J; Cottam D
    Eye (Lond); 1989; 3 ( Pt 5)():611-7. PubMed ID: 2630338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy pattern in choroidal melanoma: correlation with survival. A flow cytometry study on archival material.
    Toti P; Greco G; Mangiavacchi P; Bruni A; Palmeri ML; Luzi P
    Br J Ophthalmol; 1998 Dec; 82(12):1433-7. PubMed ID: 9930278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Al-Dahmash S; De Luca MC; Bianciotto CG; Shields CL; Ganguly A
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5721-9. PubMed ID: 23821189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA content analysis of uveal melanoma.
    McMillan J; Char DH; McLean IW; Gamel JW
    Arch Ophthalmol; 1989 Sep; 107(9):1278. PubMed ID: 2783056
    [No Abstract]   [Full Text] [Related]  

  • 19. Monosomy 3 by FISH in uveal melanoma: variability in techniques and results.
    Aronow M; Sun Y; Saunthararajah Y; Biscotti C; Tubbs R; Triozzi P; Singh AD
    Surv Ophthalmol; 2012 Sep; 57(5):463-73. PubMed ID: 22658782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of prognostic covariates for uveal melanoma.
    Gamel JW; McCurdy JB; McLean IW
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1919-22. PubMed ID: 1582798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.